O'Shaughnessy Asset Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,181	Closed	-$5K	–	1018
2016 Q2	$5K	Sell	11,181 -10,850	-49%	-$5.38K	﹤0.01%	809
2016 Q1	$10K	Buy	22,031 +9,535	+76%	+$4.65K	﹤0.01%	751
2015 Q4	$9K	Sell	12,496 -2,123	-15%	-$1.68K	﹤0.01%	756
2015 Q3	$14K	Buy	14,619 +9,420	+181%	+$11.6K	﹤0.01%	683
2015 Q2	$6K	Buy	+5,199	New	+$6.62K	﹤0.01%	825

Other funds holding ENZN

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

MCM

Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

O'Shaughnessy Asset Management's ENZN Position: Q3 2016 in Review

O'Shaughnessy Asset Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 11,181 shares — an estimated $5K sold.

O'Shaughnessy Asset Management first reported a position in ENZN in Q2 2015 and held it in 5 quarters. The position peaked at $14K in Q3 2015. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

O'Shaughnessy Asset Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
O'Shaughnessy Asset Management sold 11,181 ENZON PHARMACEUTICALS INC shares in Q3 2016, an estimated $5K.
O'Shaughnessy Asset Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2015 and held it in 5 quarters.
O'Shaughnessy Asset Management's ENZON PHARMACEUTICALS INC position peaked at $14K in Q3 2015.
4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.